409 related articles for article (PubMed ID: 19110342)
1. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
Roy K; Roy PP
Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
[TBL] [Abstract][Full Text] [Related]
2. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
3. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
4. Exploring QSAR for CYP11B2 binding affinity and CYP11B2/CYP11B1 selectivity of diverse functional compounds using GFA and G/PLS techniques.
Roy PP; Roy K
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):354-69. PubMed ID: 20030574
[TBL] [Abstract][Full Text] [Related]
5. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
6. Exploring QSARs for binding affinity of azoles with CYP2B and CYP3A enzymes using GFA and G/PLS techniques.
Roy K; Roy PP
Chem Biol Drug Des; 2008 May; 71(5):464-473. PubMed ID: 18373546
[TBL] [Abstract][Full Text] [Related]
7. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
[TBL] [Abstract][Full Text] [Related]
8. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.
Roy PP; Roy K
Chem Biol Drug Des; 2009 Apr; 73(4):442-55. PubMed ID: 19291105
[TBL] [Abstract][Full Text] [Related]
9. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
10. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
Roy K; Roy PP
Chem Biol Drug Des; 2008 Nov; 72(5):370-82. PubMed ID: 19012573
[TBL] [Abstract][Full Text] [Related]
11. Docking and 3D QSAR studies of protoporphyrinogen oxidase inhibitor 3H-pyrazolo[3,4-d][1,2,3]triazin-4-one derivatives.
Roy K; Paul S
J Mol Model; 2010 Jan; 16(1):137-53. PubMed ID: 19543755
[TBL] [Abstract][Full Text] [Related]
12. A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors.
Poso A; Gynther J; Juvonen R
J Comput Aided Mol Des; 2001 Mar; 15(3):195-202. PubMed ID: 11289074
[TBL] [Abstract][Full Text] [Related]
13. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.
Mitra I; Saha A; Roy K
J Mol Model; 2012 Aug; 18(8):3951-67. PubMed ID: 22434311
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
Rahnasto M; Raunio H; Poso A; Wittekindt C; Juvonen RO
J Med Chem; 2005 Jan; 48(2):440-9. PubMed ID: 15658857
[TBL] [Abstract][Full Text] [Related]
15. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.
Roy PP; Roy K
J Mol Model; 2010 Oct; 16(10):1597-616. PubMed ID: 20195667
[TBL] [Abstract][Full Text] [Related]
16. Comparative QSAR analyses of competitive CYP2C9 inhibitors using three-dimensional molecular descriptors.
Lather V; Fernandes MX
Chem Biol Drug Des; 2011 Jul; 78(1):112-23. PubMed ID: 21477091
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Roy PP; Roy K
J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
[TBL] [Abstract][Full Text] [Related]
18. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools.
Mitra I; Roy K; Saha A
J Comput Chem; 2009 Dec; 30(16):2712-22. PubMed ID: 19399769
[TBL] [Abstract][Full Text] [Related]
19. Conceptual DFT properties-based 3D QSAR: analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
Van Damme S; Bultinck P
J Comput Chem; 2009 Sep; 30(12):1749-57. PubMed ID: 19090569
[TBL] [Abstract][Full Text] [Related]
20. QSAR modeling of toxicity of diverse organic chemicals to Daphnia magna using 2D and 3D descriptors.
Kar S; Roy K
J Hazard Mater; 2010 May; 177(1-3):344-51. PubMed ID: 20045248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
